Discovery of primary prostate cancer biomarkers using cross cancer learning
Abstract Prostate cancer (PCa), the second leading cause of cancer death in American men, is a relatively slow-growing malignancy with multiple early treatment options. Yet, a significant number of low-risk PCa patients are over-diagnosed and over-treated with significant and long-term quality of li...
Enregistré dans:
Auteurs principaux: | Kaiyue Zhou, Suzan Arslanturk, Douglas B. Craig, Elisabeth Heath, Sorin Draghici |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ce495cea89524f4a9f69c416fc8a182a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Discovery proteomics defines androgen-regulated glycoprotein networks in prostate cancer cells, as well as putative biomarkers of prostatic diseases
par: Jordy J. Hsiao, et autres
Publié: (2021) -
Integrative epigenetic taxonomy of primary prostate cancer
par: Suzan Stelloo, et autres
Publié: (2018) -
Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay
par: Shiqin Liu, et autres
Publié: (2021) -
Biomarkers for Treatment Response in Advanced Prostate Cancer
par: Samia Asif, et autres
Publié: (2021) -
Biomarkers for Prostate Cancer Diagnosis from Genetic Perspectives
par: Fatemeh Khatami, et autres
Publié: (2020)